Enrichment analysis of genes dysregulated following Resveratrol treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00014251
TitleEnrichment analysis of genes dysregulated following Resveratrol treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Resveratrol treated cells and untreated control cells in the vastus lateralis muscle cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3087068
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis CuratorMicrotaskManic
CREEDS IDdrug:3499
Cell Typevastus lateralis muscle
Drug NameResveratrol
DrugBank IDDB02709
Organismhuman
SMILES IDOc1ccc(cc1)/C=C/c1cc(O)cc(c1)O
Characteristic Direction parameters
Control SamplesGSM801199, GSM801201, GSM801202, GSM801204, GSM801206, GSM801208, GSM801211, GSM801212, GSM801214, GSM801216
Perturbed SamplesGSM801198, GSM801200, GSM801203, GSM801205, GSM801207, GSM801209, GSM801210, GSM801213, GSM801215, GSM801217
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE32357
Gene Expression Omnibus
Resveratrol (resVida) effect on obese men: vastus lateralis muscle biopsies
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.